Browse > Article
http://dx.doi.org/10.4196/kjpp.2010.14.4.199

The Efficacy of Shikonin on Cartilage Protection in a Mouse Model of Rheumatoid Arthritis  

Kim, Young-Ock (Department of Herbal Crop Research, National Institute of Horticultural & Herbal Science, Rural Development Administration)
Hong, Seung-Jae (Department of Rheumatology, School of Medicine, Kyung Hee University)
Yim, Sung-Vin (Department of Clinical Pharmacology, School of Medicine, Kyung Hee University)
Publication Information
The Korean Journal of Physiology and Pharmacology / v.14, no.4, 2010 , pp. 199-204 More about this Journal
Abstract
The potential therapeutic action of shikonin in an experimental model of rheumatoid arthritis (RA) was investigated. As a RA animal model, DBA/1J mice were immunized two times with type II collagen. After the second collagen immunization, mice were orally administered shikonin (2 mg/kg) once a day for 35 days, and the incidence, clinical score, bone mineral density (BMD), bone mineral content (BMC) and joint histopathology were evaluated. BMD in the proximal regions of the tibia largely increased in the shikonin treatment group compared with the control group. We also examined the effect of shikonin on inflammatory cytokines and cartilage protection. Shikonin treatment significantly reduced the incidence and severity of collagen-induced arthritis (CIA), markedly abrogating joint swelling and cartilage destruction. Shikonin also significantly inhibited the production of matrix metalloproteinase (MMP)-1 and up-regulated tissue inhibitors of metalloproteinase (TIMP)-1 in mice with CIA. In conclusion, shikonin exerted therapeutic effects through regulation of MMP/TIMP; these results suggest that shikonin is an outstanding candidate as a cartilage protective medicine for RA.
Keywords
Shikonin; Bone mineral density; Bone mineral contents; MMP-1; TIMP-1;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 3
연도 인용수 순위
1 LI, Moon WS, Cho NP, Cho SD, Bae TS, Kim BI, Soh YJ. Hexane-soluble fraction of the common Fig, Ficus carica, inhibits osteoclast differentiation in murine bone marrow-derived macrophages and raw 264.7. Korean J Physiol Pharmacol. 2009;13:417-424.   과학기술학회마을   DOI   ScienceOn
2 Goldring SR, Gravallese EM. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol. 2000;12:195-199.   DOI   ScienceOn
3 Jones SA, Kennedy AJ, Roberts NA. Assessment of drugs for activity in established type II collagen arthritis. Agents Actions. 1982;12:650-656.   DOI   ScienceOn
4 Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2:1269-1275.   DOI   ScienceOn
5 Ishida T, Sakaguchi I. Protection of human keratinocytes from UVB-induced inflammation using root extract of Lithospermum erythrorhizon. Biol Pharm Bull. 2007;30:928-934.   DOI   ScienceOn
6 Ahmed M, Khanna D, Furst DE. Meloxicam in the rheumatoid arthritis. Expert Opin Drug Metab Toxicol. 2005;1:739-751.   DOI   ScienceOn
7 Choi S, Lee YA, Hong SJ, Lee GJ, Kang SW, Park JH, Park JH, Park HK. Evaluation of inflammatory change and bone erosion using a murine type II collagen-induced arthritis model. Rheumatol Int. 2010 [Epub ahead of print].
8 Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, Breedveld FC, Huizinga TW. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis. 2002;61:975-980.   DOI   ScienceOn
9 Enokida M, Yamasaki D, Okano T, Hagino H, Morio Y, Teshima R. Bone mass changes of tibial and vertebral bones in young and adult rats with collagen-induced arthritis. Bone. 2001;28:87-93.   DOI   ScienceOn
10 Chikanza IC, Kingsley G, Panayi GS. Peripheral blood and synovial fluid monocyte expression of interleukin $1\alpha$ and $TNF-\alpha$ during active rheumatoid arthritis. J Rheumatol. 1995;22:600- 606.
11 Campagnuolo G, Bolon B, Feige U. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. Arthritis Rheum. 2002;46:1926-1936.   DOI   ScienceOn
12 Imaizumi K, Hinoue H, Ueno M, Takata I, Sato T, Minato Y, Takeshita M, Okaniwa A. Histopathological study of arthritic lesions induced by immunization with type II collagen in DBA/1J mouse. Jikken Dobutsu. 1990;39:27-34.
13 Hur GM, Hwang YB, Lee JH, Bae SH, Park JS, Lee CJ, Seok JH. Caffeic acid phenethyl ester inhibits the PKC- induced IL-6 gene expression in the synoviocytes of rheumatoid arthritis patients. Korean J Physiol Pharmacol. 2003;7:363-368.   과학기술학회마을
14 Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis. J Rheumatol. 2004;31:238-242.
15 Matrisian L. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990;6:121-125.   DOI   ScienceOn
16 Garnero P, Geusens P, Landewe R. Biochemical markers of joint tissue turnover in early rheumatoid arthritis. Clin Exp Rheumatol. 2003;21:S54-S58.
17 Minne HW, Pfeilschifter J, Scharla S, Mutschelknauss S, Schwarz A, Krempien B, Ziegler R. Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass. Endocrinology. 1984;115:50-54.   DOI   ScienceOn
18 Woessner JF. Matrix metalloproteinase and their inhibitors in connective tissue remodeling. FASEB J. 1998;5:2145-2154.
19 Jackson CJ, Arkell J, Nguyen M. Rheumatoids synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann Rheum Dis. 1998;57:158-161.   DOI   ScienceOn
20 Green MJ, Gough AK, Devlin J, Smith J, Astin P, Taylor D. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology. 2003;42:82-88.
21 Jin R, Kurashige S. Effects of Chinese herbs on macrophage functions in N-butyl-N-butanolnitrosoamine treated mice. Immunopharmacol. Immunotoxicol. 1996;18:105-114.
22 Hirayama T, Danks L, Sabokbar A, Athanasou NA. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology (Oxford). 2002;41:1232- 1239.   DOI   ScienceOn
23 Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res. 2003;18:1206-1216.   DOI   ScienceOn
24 Shingu M, Nagai Y, Isayama T, Naono T, Nobunaga M, Nagai Y. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol. 1993;94:145-149.
25 Lee HG. Bone Cho Kang Mook [compendium of material medica]. Seoul: Yeoil; 2007 (in Korean)
26 Vassilios PP, Assimopoulou AN, Couladouros EA, Hepworth D, Nicolaou KC. The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angew Chem Int. 1999;38:270-301.   DOI   ScienceOn
27 Chung, HS, Kang M, Cho C, Park S, Kim H, Yoon YS, Kang J, Shin MK, Hong MC, Bae H. Inhibition of lipopolysaccharide and interferon-gamma-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by Lithospermi radix in mouse peritoneal macrophages. J Ethnopharmacol. 2005;102:412-417.   DOI   ScienceOn
28 Jin R, Wan LL, Mitsuishi T, Kodama K, Kurashige S. Immunomodulative effects of Chinese herbs in mice treated with anti-tumor agent cyclophosphamide. Yakugaku. Zasshi. 1994; 114:533-538.
29 Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NF kappa B ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone. 2002;30:340- 346.   DOI   ScienceOn